Stay updated on IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial page.

Latest updates to the IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial page
- CheckyesterdayChange DetectedDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe record history now shows a new Revision tag, v3.6.4, replacing the previous v3.6.3, indicating a small software update to the page rather than changes to the study data.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedA new revision entry, Revision: v3.6.3, was added to the study record history, replacing the previous Revision: v3.6.2. This is a metadata update to the page’s version history.SummaryDifference0.1%

- Check43 days agoChange DetectedA new revision label v3.6.2 was added and the previous v3.6.0 removed in the study history. This indicates a newer saved version of the record.SummaryDifference0.1%

- Check58 days agoChange DetectedThe recruitment status was updated to indicate enrollment has closed, and a new document revision (v3.6.0) was added while the previous revision (v3.5.5) was removed.SummaryDifference0.3%

- Check65 days agoChange DetectedA new revision tag v3.5.5 has been added to the record history. The previous revision v3.5.4 has been removed.SummaryDifference0.1%

Stay in the know with updates to IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial page.